Form 4: Viemed CFO's Equity Compensation Update

Viemed Healthcare's CFO, Trae Fitzgerald, reported recent equity compensation transactions including RSU vesting, tax-related share dispositions, and new RSU and Phantom Share Unit grants.

Summary

• Trae Fitzgerald, Chief Financial Officer of Viemed Healthcare, Inc. (VMD), reported changes in beneficial ownership of common shares.
• On January 17, 2026, 9,590 Restricted Stock Units (RSUs) granted on January 17, 2023, vested, resulting in the acquisition of 9,590 common shares.
• Concurrently, 3,132 common shares were disposed of to satisfy tax obligations related to the RSU vesting, based on a market closing price of $7.33 per share on January 16, 2026.
• Also on January 17, 2026, 2,397 Phantom Share Units granted on January 17, 2023, vested and were settled in cash, which is reported as an acquisition and simultaneous disposition of 2,397 common shares.
• Following these transactions, beneficial ownership of common shares was 89,452.
• On January 19, 2026, Mr. Fitzgerald was granted 46,662 new Restricted Stock Units (RSUs) and 11,666 new Phantom Share Units.
• The newly granted RSUs and Phantom Share Units will vest in three equal annual installments beginning on the first anniversary of the grant date, with an expiration date of January 19, 2029.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to equity compensation, which are neither inherently positive nor negative for the company's immediate operational or financial outlook.

Positives

• Acquired 9,590 common shares from the vesting of Restricted Stock Units.
• Received new grants of 46,662 Restricted Stock Units, aligning executive incentives with future company performance.
• Received new grants of 11,666 Phantom Share Units, providing additional equity-linked compensation.

Negatives

• Disposed of 3,132 common shares to cover tax obligations from RSU vesting, reducing direct share ownership.
• Cash settlement of 2,397 Phantom Share Units resulted in a disposition of underlying common shares for cash.

Future Outlook

The newly granted Restricted Stock Units and Phantom Share Units will vest in three equal annual installments, beginning on the first anniversary of the January 19, 2026 grant date, with full vesting by January 19, 2029.

Industry Context

This filing reflects routine equity compensation practices common in the healthcare services industry for executive retention and incentive alignment.

Stakeholder Impact

• Shareholders: The equity grants align the Chief Financial Officer's interests with shareholder value creation through long-term incentives.
• Employees: Reflects standard executive compensation practices, potentially influencing broader compensation strategies within the company.

Next Steps

• Future vesting of the 46,662 Restricted Stock Units and 11,666 Phantom Share Units will occur in three equal annual installments starting January 19, 2027, through January 19, 2029.

Key Dates

Keywords

Viemed Healthcare, VMD, Form 4, Insider Transaction, Equity Compensation, Restricted Stock Units, RSU, Phantom Share Units, CFO, Stock Vesting, Share Grant